We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surgical Technique Might Cure High Blood Pressure

By HospiMedica International staff writers
Posted on 05 Jan 2010
A revolutionary new surgical system and procedure could reduce the risk of a major heart attack or stroke in those patients with persistent high blood pressure on whom medication has no effect.

The Symplicity Catheter System uses controlled, low-power radiofrequency (RF) energy to deactivate the renal nerves, thereby selectively reducing both the pathologic central sympathetic drive to the kidney, and the renal contribution to central sympathetic hyperactivity. More...
The system has two main components, designed to work together as an integrated system to ensure consistent performance. The first is the Symplicity catheter, a low profile energy delivery catheter that delivers RF energy through the arterial wall to the renal nerves, which has an atraumatic, radiopaque, tip that minimizes risk of arterial injury and is easily visualized under fluoroscopy. The second component is the Symplicity generator, a fully automated, compact, RF generator with hands-free pedal activation and built-in control mechanisms and temperature and impedance monitoring functions to protect against excess energy delivery.

The surgical procedure, called renal sympathetic-nerve ablation, is a minimally invasive procedure that takes about 40 minutes, and patients recover quickly and can soon return to their daily lives. The Symplicity Catheter System is under development by Ardian (Palo Alto, CA, USA), and is undergoing clinical studies in patients with resistant hypertension and chronic kidney disease in centers across the United States, Europe, and Australia.

"This is the most exciting development in hypertension since the advent of antihypertensive medication 50 years ago. It is hard to forecast the limitations and it could eventually be compared to medication,” said Mel Lobo, M.D., a specialist in clinical hypertension with the United Kingdom National Health Service (NHS, London, United Kingdom).

The renal sympathetic nerves have been identified as a major contributor to the complex pathophysiology of hypertension, in both experimental models and in humans. Patients with essential hypertension generally have increased efferent sympathetic drive to the kidneys, as evidenced by elevated rates of renal norepinephrine spillover into the circulation. Hypertension is also characterized by an increased rate of sympathetic-nerve firing, possibly modulated by afferent signaling from renal sensory nerves.

Related Links:
Ardian
United Kingdom National Health Service


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.